The immune response in leishmaniasis may result in a polarization of the T lymphocyte subpopulation, altering cell phenotype and resulting in immune protection or disease exacerbation. Leishmania may persist in the body either during asymptomatic infections or after treatment, which represents high risk under immunosuppression. The objective of this study was to evaluate the effect of infection with immunosuppression by dexamethasone associated with pentoxifylline on animal weight, spleen weight, spleen and hepatic parasitic load and immunopathology, as well as the IFN-γ and IL-10 production in spleen cell culture of Balb/c mice infected with Leishmania chagasi. The infection did not cause body weight gain in animals, but both the weight and size of the spleen were increased. The immunosuppression using dexamethasone associated with pentoxifylline affected body weight gain and spleen weight and size in both infected and non-infected animals. The immunosuppression did not significantly alter the course of the splenic or hepatic parasite burden. Dexamethasone and pentoxifylline significantly affected cytokine production, but did not influence the Th1/Th2 ratio in infected animals.
INTRODUCTION
Leishmaniasis is caused by intracellular protozoa of the genus Leishmania, order Kinetoplastida, family Trypanosomatidae. They are heteroxenous parasites that require two hosts to complete their life cycle, namely a vertebrate and an invertebrate, particularly hematophagus flies of the genus Phlebotomus, order Diptera (1) . Leishmania presents a spherical form and are non-mobile and without flagellum when in vertebrate hosts, called amastigote, and a flagellated form in mosquitoes, denominated promastigote (2).
In experimental infections by the genus Leishmania, host resistance or susceptibility to the parasite is determined by differentiation of T lymphocytes into the subpopulations Th1 or Th2 (3) . Recent studies -especially concerning leishmaniasis agents in humans, i.e. L. major -define the Th1/Th2 paradigm as indicator of the resistance/susceptibility to the infection as well as indicate the role of IL-12 and IL-4, which is to provoke the development of Th1 and Th2 cells (4) . However, similar patterns have not been observed in infections provoked by L. donovani and L.
chagasi, both agents of visceral leishmaniasis in humans (5).
The most studied visceral leishmaniasis model is the Balb/c mouse lineage infected with L. donovani or L. chagasi (6) . The course of visceral infection by L. chagasi in a Balb/c mouse strictly mimics the infection by L. donovani, since the mouse initially expresses a susceptible phenotype, but subsequently develops its self-cure (7) . Most studies employing strains of visceral leishmaniasis have been performed with 10 7 parasites per mouse, although variability among injection doses has limited the comparison of results (8) . Infection by L. donovani in mice results in early increase of parasite burden and its subsequent control during the infection course (7) . The hepatic infection is usually self-limited -an example of granulomatous inflammatory response predominantly composed of mononuclear cells -with multiple cytokines including mainly IFN-γ, IL-12, IL-4 and moderate levels of TNF-α, all produced in the hepatic granuloma (9) . Simultaneous to the hepatic infection resolution, a growth of amastigote forms occurs in the spleen (10) . The persistence of parasites in this organ is followed by failure to form granulomas and splenomegaly provoked by alteration of lymphatic tissue microstructure and augmentation of hematopoietic activity (11) .
While immunological response of experimental cutaneous leishmaniasis has been extensively studied, the characteristics of immune response to visceral leishmaniasis are still not fully understood (12) .
The protective role of IL-12 in visceral leishmaniasis was attributed to its ability to activate macrophages, thus increasing killing activity. IL-12 produced by infected macrophages induces natural-killer-cell (NK) activation, Th1 cell differentiation and IFN-γ production (4). INF-γ, in turn, stimulates production of nitric oxide by macrophages, which is responsible for parasite destruction and infection resistance Glucocorticoids, including hydrocortisone acetate and dexamethasone, are immunosuppressive antiinflammatory drugs that, when used alone or in combination, may alter the course of infection by Toxoplasma gondii and leishmania (16) .
Dexamethasone is well known for its numerous immunosuppressive properties, especially regarding production of pro-inflammatory cytokines such as IL-2 e IFN-γ (17) . However, their effects on the Th1/Th2 profile are still unclear (15) .
Immunomodulating properties of pentoxifylline and its synergetic inhibitory effects with glucocorticoids make this drug a potential supporting agent for treatment of human autoimmune diseases (17) . Several pentoxifylline effects at the cellular level comprise modulation of cytokine production in a dose-dependent pattern namely TNF-α synthesis by macrophages, synthesis of IL-2, IL-12 and INF-γ, and influence on the production of other cytokines including IL-4, IL-6 and IL-10. These properties indicate that pentoxifylline may act by stimulating alterations on Th1 cellular response to Th2 (3).
In the face of the growing incidence and severity of visceral leishmaniasis cases in immunosuppressed hosts, knowledge on immunological behavior is extremely important. Experimental studies are fundamental to better understand how host immune response works, which may enable the development of vaccines to prevent the disease in humans and other animals and permit the use of exogenous cytokines that may aid the recovery of infected immunosuppressed patients (18) .
In the present study, the effects of leishmania infection and immunosuppression on body and spleen weight, splenic and hepatic parasite burden as well as immunopathological aspects related to IFN-γ and IL-10 production in spleen cell culture were applied to comparatively evaluate the infection in immunosuppressed and non-immunosuppressed animals.
MATERIALS AND METHODS

Animals
Isogenic male Balb/c mice aged seven weeks were utilized. Animals were divided into four experimental groups, Group 1 (G1): 16 non-infected and non- On the infection date, denominated day zero, groups G3 and G4 were anesthetized following the protocol of Curl and Peters (20) . Then, each animal was infected with 10 7 amastigotes intravenously in the infraorbital foramen. Groups G1 and G2 were also anesthetized and inoculated with water, at the same volume and by the same route. 
Immunossuppression
Parasite burden
Parasite burden was assessed by the culture microtitration technique as described by Buffet et al. (21) .
Spleen cell culture supernatant
In order to obtain the supernatant of spleen cell culture, approximately half of the spleen from each mouse was removed, placed on Petri dishes containing 5 mL of RPMI 1640 cell culture medium and crushed. Material was collected and centrifuged in 15-mL Falcon tubes for 10 minutes at 1,500 rpm, at 4°C. Subsequently, supernatant was discharged and the cell sediment was harvested by homogenization in 2 mL of cell culture complete medium [CCCM: RPMI 1640 added to 10%
inactive/sterile bovine fetal serum, 1% penicillin/streptomycin (respectively, 10,000 UI/mL and 10 mg/mL) and enriched with 1% L-glutamine]. After counting, the final concentration was adjusted to 5x10 6 cells/mL. Cells were tested in triplicate on 48-well microculture plates, immediately complemented with 100 µL of CCCM, and stimulated with 10 µg/mL of mitogen concanavalin-A and 10 µg/mL of Leishmania chagasi antigen (8) . The plates were incubated at 37°C, with 5% CO 2 for 48 hours, after which supernatant was harvested and stored at -80 o C for subsequent cytokine processing and analysis.
The antigen was obtained from a culture of Leishmania chagasi promastigotes in 30 to 40 mL of Schneider's Drosophila medium, supplemented with 20% inactive/sterile bovine fetal serum and penicillin/streptomycin (10,000 UI/mL and 10 mg/mL, respectively), for 10 to 15 days at 28°C. After this period, culture was centrifuged at 3,000 rpm for 10 minutes in 50 mL Falcon tubes. Media were discharged and sediment was re-suspended in 10 mL of phosphate buffered saline solution (PBS), 0.01 M, pH 7.2, sterile. The material was re-centrifuged at 3,000 rpm for 10 minutes, thus to discharge the supernatant. This process was repeated twice and final supernatant was homogenized, aliquoted and stored at -20°C until sonicated.
Sonicator was adjusted for six more cycles of 50% potency, at 4°C, for 30 seconds. 
Statistical analysis
To compare groups of all variables in the present study (body weight, spleen weight, cytokines and parasite burden) at each observation moment, Kruskal-Wallis test was (23, 24) .
RESULTS AND DISCUSSION
Results presented herein refer to the more representative of the two independently performed experiments. As shown in Figure 4 , the parasite burden in the G3 liver decreased during the study period, probably due to particular characteristics of this organ, specifically its ability to generate granulomas, which strengthens hepatic resistance against leishmaniasis (10, 11) . On the 30 th day, the hepatic burden was higher than the splenic burden (Figures 4 and 5) . On the 60 th PI day, an inversion -i.e. splenic parasite burden increase and hepatic burden decrease -was observed and persisted until the 90 th day, which may have occurred because during L. chagasi infection in mice, amastigotes rapidly multiply in the liver for the first four weeks. In the spleen, the increase of parasite number is slower and the liver apparently serves as initial location for parasite expansion, while the spleen may be responsible for infection persistence (13, 28) . A higher parasite burden in G4 (immunosuppressed group) was observed on days 75
and 90 (Figures 4 and 5) , which suggests that the drugs had affected the infection control in these animals. Despite imunossupression, no statistical difference was observed between parasite burdens in G3 and G4, which differs from results obtained by Gangneux et al. (16) . In the current study, mice treated with dexamethasone and pentoxifylline from the 10 th to the 40 th PI day presented a significantly increased parasite burden in both the spleen and liver. Analysis revealed a smaller cytokine production of IFN-γ compared to the control group, whereas IL-4 concentration did not differ among the three groups. These results suggest that augmented parasite burden may not be associated with either specific cell immunophenotype of the spleen or with Th1 and Th2 cytokine secretion profile.
Similar levels of IFN-γ and IL-10 were observed in both non-stimulated ( Figures 6   and 7 ) and antigen-specific-stimulated cultures (Figures 8 and 9) , showing that cytokine production can be activated by different pathways.
IFN-γ levels were not statistically associated with a diminished parasite burden (p > 0.05) (data not shown). However, detectable IFN-γ levels were observed ( Figure 6) on days 75 and 90 only in G3 and not in G4 (immunosuppressed group), which may be due to the role of IFN-γ in the parasite burden of these groups, which was lower in G3 and higher in G4 (Figures 4 and 5) . (29) reported that high INF-γ levels were accompanied by parasite burden reduction.
However, Ansari et al. (30) suggested that despite the presence of elevated INF-γ levels during infection, the host may fail to control the disease due to an incomplete response to INF-γ. The peak levels on the 60 th day in groups G3 and G4 may be related to infection control, since some reports have shown that this control initiates approximately four weeks after the infection (6, 9, 31).
IL-10 was detectable during the whole experiment in G3 and G4 (Figures 7 and 9 ). However, IL-10 levels are lower in the infected groups (G3 and G4) than in G1 and G2, on the 30 th and 60 th days. 
CONCLUSIONS
The infection of mice with Leishmania chagasi strain M6445 did not alter body weight gain, but influenced on size and weight of the spleen. Immunosuppression with dexamethasone associated with pentoxifylline modified both body weight and the size and weight of the spleen of infected and non-infected animals.
Immunosuppression with dexamethasone and pentoxifylline did not significantly alter the parasite burden course in the spleen or liver. However, it affected tested cytokines, without altering the Th1/Th2 profile response in infected animals. 
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